The novel GLP-1/GIP dual agonist DA3-CH improves rat type 2 diabetes through activating AMPK/ACC signaling pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The novel GLP-1/GIP dual agonist DA3-CH improves rat type 2 diabetes through activating AMPK/ACC signaling pathway

Published:2023-10-17 Issue: Volume: Page:
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Xu Jing¹²,Chen Peng³,Wu Dongzhi⁴,Zhou Qiang¹,Chen Sijie¹,Ding Xiang¹,Xiong Hongping¹²

Affiliation:

1. Department of Endocrinology, Fuzhou Second Hospital, Fuzhou 350007, Fujian Province, China

2. The Third Clinical Medical College, Fujian Medical University, Fuzhou 362002, Fujian Province, China

3. Department of Internal Neurology, Fuzhou Second Hospital, Fuzhou 350007, Fujian Province, China

4. Department of Orthopedics Institute, Fuzhou Second Hospital, Fuzhou 350007, Fujian Province, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference21 articles.

1. GLP-1 Analogs and DPP-4 Inhibitors in Type 2 Diabetes Therapy: Review of Head-to-Head Clinical Trials.;Pratley;Front Endocrinol (Lausanne),2020

2. Effects of GLP-1 and Its Analogs on Gastric Physiology in Diabetes Mellitus and Obesity.;Camilleri;Adv Exp Med Biol,2021

3. Association Between Use of Sodium-Glucose Cotransporter 2 Inhibitors, Glucagon-like Peptide 1 Agonists, and Dipeptidyl Peptidase 4 Inhibitors With All-Cause Mortality in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis.;Meeran;JAMA,2018

4. Efficacy of GLP-1 RA Approved for Weight Management in Patients With or Without Diabetes: A Narrative Review.;Janež;Adv Ther,2022

5. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus.;Meier;Nat Rev Endocrinol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An Update on the Role and Potential Molecules in Relation to Ruminococcus gnavus in Inflammatory Bowel Disease, Obesity and Diabetes Mellitus;Diabetes, Metabolic Syndrome and Obesity;2024-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3